Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi

NCT04422418 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-11-03

No results posted yet for this study

Summary

The main objective of our project is to investigate the evolution of psychosocial, cardiovascular and immune markers in healthcare with different levels of exposure to the COVID-19 pandemic.

Conditions

  • Cardiovascular Risk Factor
  • Burnout
  • Immune Deficiency

Sponsors & Collaborators

  • Zayed Military Hospital

    collaborator OTHER_GOV
  • Abu Dhabi University

    collaborator UNKNOWN
  • Cleveland Clinic Abu Dhabi

    collaborator OTHER
  • Sheikh Khalifa Medical City

    collaborator OTHER
  • Sheikh Shakhbout Medical City

    collaborator OTHER
  • Mediclinic Middle East

    collaborator INDUSTRY
  • Myriad Global Solutions

    collaborator UNKNOWN
  • Khalifa University for Science and Technology

    lead OTHER

Principal Investigators

  • Wael Almahmeed, MD · Cleveland Clinic Abu Dhabi

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-12-14
Completion
2020-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04422418 on ClinicalTrials.gov